Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Gastroenterology Reports
Published in: Current Gastroenterology Reports 5/2010

01-10-2010

Features and Management of Colonic Diverticular Disease

Authors: Jason Hemming, Martin Floch

Published in: Current Gastroenterology Reports | Issue 5/2010

Login to get access

Abstract

Diverticular disease is one of the most prevalent gastrointestinal conditions to afflict Western populations. Although the majority of patients with diverticulosis remain asymptomatic, about one third will develop symptoms at some point in their lives. Symptomatic diverticular disease can range from chronic mild gastrointestinal distress to acute bouts of diverticulitis complicated by abscess or frank colonic perforation. The mainstay of treatment of symptomatic diverticular disease has long been bowel rest, antibiotics, and pain control, reserving surgery for those with complicated disease. This review discusses the epidemiology, pathophysiology, clinical presentation, and management of the spectrum of diverticular disease, including recent advances in the treatment of chronic diverticular disease.
Literature
1.
Painter NS, Burkitt DP: Diverticular disease of the colon: a deficiency disease of Western civilization. Br Med J 1971, 2:450–454.CrossRefPubMed
2.
Peppercorn MA: The overlap of inflammatory bowel disease and diverticular disease. J Clin Gastroenterol 2004, 38(Suppl):S8–S10.CrossRefPubMed
3.
DiMario F, Comparato G, Fanigliulo L, et al.: Use of mesalazine in diverticular disease. J Clin Gastroenterol 2006, 40(Suppl 3):S155–S159.CrossRef
4.
Floch MH, White JA: Management of diverticular disease is changing. World J Gastroenterol 2006, 12:3225–3228.PubMed
5.
Sheth A, Longo W, Floch M: Diverticular disease and diverticulitis. Am J Gastroenterol 2008, 103:1–7.CrossRef
6.
Hughes LE: Postmortem survey of diverticular disease of the colon. I Diverticulosis and diverticultis. Gut 1969, 10:336–344.CrossRefPubMed
7.
• Etzioni DA, Mack TM, Kaiser AM, et al.: Diverticulitis in the United States: 1998–2005: changing patterns of disease and treatment. Ann Surg 2009, 249:210–217. This is the first study to report dramatic changes in rates of treatment for diverticulitis in the United States, including increased rates of elective surgeries and shift toward those of younger age. CrossRefPubMed
8.
West AB, Losada M: The pathology of diverticulosis coli. J Clin Gastroenterol 2004, 38(Suppl):S11–S16.CrossRefPubMed
9.
Burkitt D: Diverticular disease of the colon epidemiological evidence relating it to fibre-depleted diets. Trans Med Soc Lond 1973, 89:81–84.PubMed
10.
Painter NS, Truelove SC, Ardan GM, et al.: Segmentation and the localization of intraluminal pressure in the human colon, with special reference to the pathogenesis of colinic diverticula. Gastroenterology 1968, 54(Suppl):778–780.PubMed
11.
• Strate LL, Lin YL, Syngal S, et al.: Nut, corn and popcorn consumption and the incidence of diverticular disease. JAMA 2008, 300:907–914. This article reports a large, prospective study of men without known diverticular disease, showing that nut, corn, and popcorn consumption did not increase the risk of diverticulosis or diverticular complications, thus questioning the long-standing recommendation to avoid such foods to prevent diverticular complications. CrossRefPubMed
12.
Floch CL: Diagnosis and management of acute diverticulitis. J Clin Gastroenterol 2006, 40(Suppl 3):S136–S144.CrossRefPubMed
13.
• Simpson J, Sundler F, Spiller RC, et al.: Post inflammatory damage to the enteric nervous system in diverticular disease and its relationship to symptoms. Neurogastroenterol Motil 2009, 21:847–858. This article describes a recent study clearly showing important alterations in the enteric nervous system, including—for the first time—a selective increase in a range of neuropeptides, which can be related to the presence of symptoms in patients with diverticulitis. CrossRefPubMed
14.
Tursi A: New physiopathological and therapeutic approaches to diverticular disease of the colon. Expert Opin Pharmacother 2007, 8:299–307.CrossRefPubMed
15.
Kohler L, Sauerland S, Neugebauer E: Diagnosis and treatment of diverticular disease: Results of a consensus development conference.The Scientific Committee of the European Association for Endoscopic Surgery. Surg Endosc 1999, 13:430–436.CrossRefPubMed
16.
17.
Kaiser A, Jiang J, Lake J, et al.: The management of complicated diverticulitis and the role of computed tomography. Am J Gastroenterol 2005, 100:910–917.CrossRefPubMed
18.
Antolovic D, Reissfelder C, Weitz J, et al.: Surgical treatment of sigmoid diverticulitis—analysis or predictive risk factors for postoperative infections, surgical complications, and mortality. Int J Colorectal Dis 2009, 24:577–584.CrossRefPubMed
19.
Ravo B, Khan SA, Ger R, et al.: Unusual extraperitoneal presentations of diverticulitis. Am J Gastroenterol 1985, 80:346–351.PubMed
20.
Najjar SF, Jamal MK, Savas JF, et al.: The spectrum of colovesical fistula and diagnostic paradigm. Am J Surg 2004, 188:617.CrossRefPubMed
21.
Bordeianou L, Hodin R: Controversies in the surgical management of sigmoid diverticulitis. J Gastrointest Surg 2007, 11:542–548.CrossRefPubMed
22.
Melchior S, Cudovic D, Thuroff J, et al.: Diagnosis and surgical management of colovesical fistulas due to sigmoid diverticulitis. J Urol 2009, 182:978–982.CrossRefPubMed
23.
Tyau ES, Prystowsky JB, Joehl RJ, et al.: Acute diverticulitis. A complicated problem in the immunocompromised patient. Arch Surg 1991, 11:542–548.
24.
Saltzman DJ, Williams RA, Gelfand DV, et al.: The surgeon and AIDS: twenty years later. Arch Surg 2005, 140:961–967.CrossRefPubMed
25.
Frattini J, Longo WE: Diagnosis and treatment of chronic and recurrent diverticulitis. J Clin Gastroenterol 2006, 40(Suppl 3):S145–S149.CrossRefPubMed
26.
• Jung H, Choung RS, Talley NJ, et al.: Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenteol 2010, 105:652–661. This article describes a large, population-based, cross-sectional study that demonstrated for the first time the association of IBS and colonic diverticular disease; the association was strongest in older people. CrossRef
27.
Clemens CH, Samsom M, Smout AJ, et al.: Colorectal visceral perception in diverticular disease. Gut 2004, 53:717–722.CrossRefPubMed
28.
Spiller R: How inflammation changes neuromuscular function and its relevance to symptoms in diverticular disease. J Clin Gastroenterol 2006, 40(Suppl):S117–S120.CrossRefPubMed
29.
Mayer EA, Collins SM: Evolving pathophsyologic models of functional gastrointestinal disorders. Gastroenterology 2002, 122:2032–2048.CrossRefPubMed
30.
Costedio MM, Coates MD, Hyman NH, et al.: Serotonin signaling in diverticular disease. J Gastrointest Surg 2008, 12:1439–1445.CrossRefPubMed
31.
Bassotti G, Battaglia E, DeRoberto G, et al.: Alterations in colonic motility and relationship to in pain in colonic diverticulosis. Clin Gastroenterol Hepatol 2005, 3:248–253.CrossRefPubMed
32.
Tursi A: Mesalazine for diverticular disease of the colon—a new role for an old drug. Expert Opin Pharmacother 2005, 6:69–74.CrossRefPubMed
33.
Goldstein NS, Leon-Armin C, Mani A: Crohn's colitis-like changes in sigmoid diverticulitis specimens is usually an idosyncratic inflammatory response to the diverticulosis rather than Crohn's colitis. Am J Surg Pathol 2000, 24:668–75.CrossRefPubMed
34.
Tursi A, Brandimarte G, Aiello F, et al.: Assessment and grading of mucosal inflammation in colonic diverticular disease. Clin Gastroenterol 2008, 42:699–703.CrossRef
35.
• Tursi A, Brandimarte G, Aiello F, et al.: Faecal calprotectin in colonic diverticular disease: a case-control study. Int J Colorectal Dis 2009, 24:49–55. Because symptomatic uncomplicated DD and IBS share most symptoms, this important study suggests for the first time that fecal calprotectin may be a tool in differentiating symptomatic uncomplicated DD from IBS. CrossRefPubMed
36.
Gore S, Shepherd NA, Wilkinson SP: Endoscopic crescentic fold disease of the sigmoid colon: the clinical and histopathological spectrum of a distinct endoscopic appearance. Int J Colorectal Dis 1992, 7:76–81.CrossRefPubMed
37.
Jani N, Finkelstein S, Blumberg D, et al.: Segmental colitis associated with diverticulosis. Dig Dis Sci 2002, 47:1175–1181.CrossRefPubMed
38.
Lamps LW, Knapple WL: Diverticular disease-associated colitis. Clin Gastroenterol Hepatol 2007, 5:27–31.CrossRefPubMed
39.
Pereira MC: Diverticular disease-associated colitis: progression to severe chronic ulcerative colitis after sigmoid surgery. Gastrointest Endosc 1998, 48:520–523.CrossRefPubMed
40.
Ierardi E, Meucci G, Hassan C, et al.: Tumour necrosis factor alpha in segmental colitis associated with diverticula. Dig Dis Sci 2008, 53:1865–1868.CrossRefPubMed
41.
Hassan C, Zullo A, Morini S, et al.: Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula. Gut 2006, 55:589–590.CrossRefPubMed
42.
Rafferty J, Shellito P, Hyman N, et al.: Practice parameters for sigmoid diverticulitis. Dis Colon Rectum 2006, 49:939–944.CrossRefPubMed
43.
Stollman N, Raskin J: Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1999, 94:3110–3121.CrossRefPubMed
44.
Wolff B, Devine R: Surgical management of diverticulitis. Am Surg 2000, 66:153–156.PubMed
45.
Wong WD, Wexner SD, Lowry A, et al.: Practice parameters for the treatment of sigmoid diverticulitis—supporting documentation. The Standards Task Force. The American Society of Colon and Rectal Surgeons. Dis Colon Rectum 2000, 43:290–297.CrossRefPubMed
46.
Salem L, Veenstra DL, Sullivan SD, et al.: The timing of elective colectomy in diverticulitis: a decision analysis. J Am Coll Surg 2004, 199:904–912.CrossRefPubMed
47.
Wasvary H, Turfah F, Kadro O, et al.: Same hospitalization resection for acute diverticulitis. Am Surg 1999, 65:632–635.PubMed
48.
Constantinides VA, Tekkis PP, Athanasiou T, et al.: Primary resection with anastomosis versus Hartmann's procedure in nonelective surgery for acute colonic diverticulitis: a systematic review. Dis Colon Rectum 2006, 49:966–981.CrossRefPubMed
49.
Reissfelder C, Buhr HJ, Ritz JP: What is the optimal time of surgical intervention after an acute attack of sigmoid diverticulitis: early or late elective laparoscopic resection? Dis Colon Rectum 2006, 49:1842–1848.CrossRefPubMed
50.
Parks T: Natural history of diverticular disease of the colon. A review of 521 cases. BMJ 1969, 4:639–642.CrossRefPubMed
51.
Chapman J, Davies M, Wolff B, et al.: Complicated diverticulitis: is it time to rethink the rules? Ann Surg 2005, 242:576.PubMed
52.
Vargas HD, Ramirez RT, Hoffman GC, et al.: Defining the role of laparoscopic-assisted sigmoid colectomy for diverticulitis. Dis Colon Rectum 2000, 43:1726.CrossRefPubMed
53.
• Klarenbeek B, Veenhof A, Bergamaschi R, et al.: Laparoscopic sigmoid resection for diverticulitis decreases major morbidity rates: a randomized control trial: short-term results of the Sigma Trial. Ann Surg 2009, 249:39–44. This article reports the first randomized trial showing laparoscopic sigmoid resection is associated with reduction in major complication rates, less pain, improved quality of life, and shorter hospitalization. CrossRefPubMed
54.
Russ AJ, Obma KL, Kennedy GD, et al.: Laparoscopy improves short-term outcomes after surgery for diverticular disease. Gastroenterology 2010, 138:2267–2274, 2274.e1.CrossRefPubMed
55.
56.
Cunningham MA, Davis JW, Kaups KL: Medical versus surgical management of diverticulitis in patients under age 40. Am J Surg 1997, 174:733–735.CrossRefPubMed
57.
Ambrosetti P, Robert J, Witzig J, et al.: Incidence, outcome, and proposed management of isolated abscesses complicating acute left-sided colonic diverticulitis. A prospective study of 140 patients. Dis Colon Rectum 1992, 35:1072–1076.CrossRefPubMed
58.
Janes S, Meagher A, Frizelle FA: Elective surgery after acute diverticulitis. Br J Surg 2005, 92:133–142.CrossRefPubMed
59.
Guzzo J, Hyman N: Diverticulitis in young patients: is resection after a single attack always warranted? Dis Colon Rectum 2004, 47:1187.CrossRefPubMed
60.
Omparato G, Fanigliulo L, Di Mario F, et al.: Quality of life in uncomplicated symptomatic diverticular disease: is it another good reason for treatment? Dig Dis 2007, 25:252–259.CrossRef
61.
Brandimarte G, Tursi A: Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease. Med Sci Monit 2004, 10:P170–P173.
62.
Tursi A, Brandimarte G, Daffina R: Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis 2002, 34:510–515.CrossRefPubMed
63.
Tursi A, Brandimarte G, Giorgetti GM, et al.: Continuous versus cyclic mesalazine therapy for patients affected by recurrent symptomatic uncomplicated diverticular disease of the colon. Dig Dis Sci 2007, 52:671–674.CrossRefPubMed
64.
Colecchia A, Sandri L, Capodicasa S, et al.: Diverticular disease of the colon: new perspectives in symptom development and treatment. World J Gastroenterol 2003, 9:1385–1389.PubMed
65.
Giaccari S, Tronci S, Ferrieri A, et al.: Long-term treatment with rifaximn and lactobacilli in post-diverticulitic stenoses of the colon. Riv Eur Sci Med Farmacol 1993, 15:29–34.PubMed
66.
Tursi A, Brandimarte G, Giogetti GM, et al.: Mesalazine and or lactobacillus in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective randomized, open-label study. J Clin Gastroenterol 2006, 40:312–316.CrossRefPubMed
67.
Fric P, Zavoral M: The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol 2003, 15:313–315.CrossRefPubMed
68.
Tursi A, Brandimarte G, Giorgetti GM, et al.: Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon. Int J Colorectal Dis 2007, 22:1103–1108.CrossRefPubMed
69.
• Trivedi CD, Das KM: Emerging therapies for diverticular disease of the colon. J Clin Gastroenterol 2008, 42:1145–1151. This article is a well-written review of the evidence supporting some conventional and emerging therapies for DD and a proposed evidence-based algorithmic approach to the treatment of DD. CrossRefPubMed
70.
Papi C, Ciaco A, Koch M, et al.: Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multi-centre open trial. Diverticular Disease Study Group. Ital J Gastroenterol 1992, 24:452–456.PubMed
71.
Papi C, Ciaco A, Koch M, et al.: Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther 1995, 9:33–39.CrossRefPubMed
72.
Latella G, MT PMT, Sottili S, et al.: Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis 2003, 18:55–62.CrossRefPubMed
73.
D’Inca R, Pomerri F, Vettorato M, et al.: Interaction between rifaximin and dietary fibre in patients with diverticular disease. Aliment Pharmacol Ther 2007, 25:771–779.CrossRefPubMed
74.
Colecchia A, Vestito A, Pasqui F, et al.: Efficacy of long term cyclic administration of the poorly absorbed antibiotic rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J Gastroenterol 2007, 13:264–269.PubMed
Metadata
Title
Features and Management of Colonic Diverticular Disease
Authors
Jason Hemming
Martin Floch
Publication date
01-10-2010
Publisher
Current Science Inc.
Published in
Current Gastroenterology Reports / Issue 5/2010
Print ISSN: 1522-8037
Electronic ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-010-0126-z

Other articles of this Issue 5/2010

Current Gastroenterology Reports 5/2010 Go to the issue

ReviewPaper

Intestinal Stem Cells

ReviewPaper

Emerging Pharmacologic Therapies for Irritable Bowel Syndrome

ReviewPaper

Functional Abdominal Pain

ReviewPaper

Update on the Indications and Use of Colonic Stents

ReviewPaper

Sampling of the Intestinal Microbiota by Epithelial M Cells

ReviewPaper

Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and Progress
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits